USD 0.47
(-20.74%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 1.1 Million USD | -92.39% |
2021 | 14.48 Million USD | 14.41% |
2020 | 12.65 Million USD | 206.09% |
2019 | 4.13 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 41.28 Million USD | 39.65% |
2015 | 29.56 Million USD | 1.76% |
2014 | 29.05 Million USD | -14.0% |
2013 | 33.78 Million USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 528 Thousand USD | 0.0% |
2024 Q1 | 835 Thousand USD | 0.0% |
2023 Q2 | 508 Thousand USD | -37.13% |
2023 FY | - USD | -100.0% |
2023 Q1 | 808 Thousand USD | -26.68% |
2023 Q4 | - USD | -100.0% |
2023 Q3 | 205 Thousand USD | -59.65% |
2022 Q4 | 1.1 Million USD | -92.68% |
2022 Q3 | 15.05 Million USD | 1.39% |
2022 FY | 1.1 Million USD | -92.39% |
2022 Q1 | 14.65 Million USD | 1.21% |
2022 Q2 | 14.84 Million USD | 1.29% |
2021 Q2 | 14.13 Million USD | -0.88% |
2021 Q3 | 14.3 Million USD | 1.22% |
2021 Q4 | 14.48 Million USD | 1.25% |
2021 FY | 14.48 Million USD | 14.41% |
2021 Q1 | 14.25 Million USD | 12.63% |
2020 Q1 | 3.92 Million USD | -5.18% |
2020 Q4 | 12.65 Million USD | 188.05% |
2020 Q3 | 4.39 Million USD | -12.19% |
2020 FY | 12.65 Million USD | 206.09% |
2020 Q2 | 5 Million USD | 27.62% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | 4.53 Million USD | 0.0% |
2019 Q4 | 4.13 Million USD | -4.66% |
2019 Q3 | 4.33 Million USD | -4.32% |
2019 FY | 4.13 Million USD | 0.0% |
2018 Q1 | 1000.00 USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | -100.0% |
2018 Q2 | 188 Thousand USD | 18700.0% |
2017 Q3 | 177 Thousand USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q4 | - USD | -100.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2016 Q1 | 29.97 Million USD | 1.39% |
2016 Q3 | 40.71 Million USD | 1.42% |
2016 Q2 | 40.14 Million USD | 33.91% |
2016 Q4 | 41.28 Million USD | 1.41% |
2016 FY | 41.28 Million USD | 39.65% |
2015 FY | 29.56 Million USD | 1.76% |
2015 Q1 | 25.81 Million USD | -11.16% |
2015 Q2 | 24.37 Million USD | -5.56% |
2015 Q4 | 29.56 Million USD | 1.41% |
2015 Q3 | 29.15 Million USD | 19.6% |
2014 Q2 | 39.66 Million USD | 0.0% |
2014 FY | 29.05 Million USD | -14.0% |
2014 Q4 | 29.05 Million USD | -11.26% |
2014 Q1 | - USD | -100.0% |
2014 Q3 | 32.73 Million USD | -17.45% |
2013 FY | 33.78 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | 33.78 Million USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 100.0% |
AngioDynamics, Inc. | 3.93 Million USD | 100.0% |
AtriCure, Inc. | 60.59 Million USD | 100.0% |
Azenta, Inc. | 60.43 Million USD | 100.0% |
BioLife Solutions, Inc. | 18.31 Million USD | 100.0% |
The Cooper Companies, Inc. | 2.52 Billion USD | 100.0% |
Daxor Corporation | 755.65 Thousand USD | 100.0% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | 100.0% |
Femasys Inc. | 4.25 Million USD | 100.0% |
GlucoTrack, Inc. | 196 Thousand USD | 100.0% |
Harvard Bioscience, Inc. | 30.7 Million USD | 100.0% |
Hologic, Inc. | 2.49 Billion USD | 100.0% |
ICU Medical, Inc. | 1.57 Billion USD | 100.0% |
Intuitive Surgical, Inc. | -82.1 Million USD | 100.0% |
KORU Medical Systems, Inc. | 3.65 Million USD | 100.0% |
LeMaitre Vascular, Inc. | 16.62 Million USD | 100.0% |
Innovative Eyewear, Inc. | - USD | NaN% |
Innovative Eyewear, Inc. | - USD | NaN% |
Masimo Corporation | 871.7 Million USD | 100.0% |
Microbot Medical Inc. | 40 Thousand USD | 100.0% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | 100.0% |
Merit Medical Systems, Inc. | 823.01 Million USD | 100.0% |
Nephros, Inc. | 1.39 Million USD | 100.0% |
NovoCure Limited | 596.24 Million USD | 100.0% |
NEXGEL, Inc. | 513 Thousand USD | 100.0% |
NEXGEL, Inc. | 513 Thousand USD | 100.0% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 100.0% |
OraSure Technologies, Inc. | 11.38 Million USD | 100.0% |
Pro-Dex, Inc. | 7.53 Million USD | 100.0% |
Pulse Biosciences, Inc. | 8.08 Million USD | 100.0% |
Predictive Oncology Inc. | 2.18 Million USD | 100.0% |
Precision Optics Corporation, Inc. | 1.93 Million USD | 100.0% |
QuidelOrtho Corporation | 2.27 Billion USD | 100.0% |
Repligen Corporation | 510.14 Million USD | 100.0% |
Sanara MedTech Inc. | 9.11 Million USD | 100.0% |
STAAR Surgical Company | 31.46 Million USD | 100.0% |
Sharps Technology, Inc. | - USD | NaN% |
Utah Medical Products, Inc. | 295 Thousand USD | 100.0% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 100.0% |
Jin Medical International Ltd. | - USD | NaN% |